x
x
x
x

Wed, December 20, 2023

Reminder: WADA’s 2024 Prohibited List comes into force on 1 January 2024

Reminder: WADA’s 2024 Prohibited List comes into force on 1 January 2024

The World Anti-Doping Agency (WADA) has issued a reminder that the 2024 Prohibited List comes into force on 1 January 2024. 

The Prohibited List is mandatory for all WADA Code signatories and designates what substances and methods are prohibited both in- and out-of-competition and which substances are banned in particular sports. 

WADA Director General Olivier Niggli said: “We encourage athletes, their entourage and all stakeholders to acquaint themselves with the Summary of Major Modifications to avoid inadvertent use of substances and methods that are prohibited in sport for 2024. In particular, we kindly ask all Anti-Doping Organizations around the world to share the List and its related documents with athletes, their entourage and other relevant stakeholders under their jurisdiction.”

The significant changes include tramadol being prohibited from 1 January 2024. On 23 September 2022, the Executive Committee endorsed the recommendation by WADA’s List Expert Advisory Group to prohibit tramadol with the delay being implemented to allow enough time for stakeholders to learn and adapt to this change. 

You can read the WADA statement here.  

Share

Recent News Articles

Fri, April 26, 2024

USA Track & Field expands maternity policy, giving athletes more time

USA Track and Field will extend maternity support for elite athletes beyond the year of support offered by the U.S. Olympic and Paralympic Committee

Read More

Thu, April 25, 2024

Sport Resolutions Annual Conference 2024 in association with Winston & Strawn LLP is Sold Out

The SR Team is thrilled to announce that the Sport Resolutions Annual Conference 2024 has reached full capacity!

Read More

Wed, April 24, 2024

Full Conference Agenda announced

We are delighted to announce the full agenda for the Sport Resolutions Annual Conference 2024 in association with Winston & Strawn LLP

Read More